Skip to main content
Top
Published in: Endocrine 2/2015

01-03-2015 | Original Article

Nodal metastasis and recurrence in papillary thyroid microcarcinoma

Authors: Adolfo Pisanu, Alessandra Saba, Mauro Podda, Isabella Reccia, Alessandro Uccheddu

Published in: Endocrine | Issue 2/2015

Login to get access

Abstract

Despite the majority of papillary thyroid microcarcinoma (PTMC) patients has benign clinical courses, some PTMCs have a clinical presentation similar to conventional papillary thyroid carcinoma (PTC). The aim of this study was to identify risk factors for lymph node metastasis at presentation and prognostic parameters influencing nodal recurrence in PTMC. From January 1998 to October 2013, 556 consecutive patients had a diagnosis of differentiated thyroid carcinoma in our surgical department. A total of 219 (39.4 %) patients who had a pathological diagnosis of PTMC represented the cohort for the current study. We carried out a retrospective cohort study to compare 24 PTMC patients with lymph node metastasis at diagnosis (N1) and 195 PTMC patients without lymph node involvement (N0). The comparison between groups involved evaluation of patients and tumor characteristics. A diameter >8 mm, the presence of multifocality, and extrathyroid invasion (T3) were independent risk factors for nodal involvement at presentation. The presence of T3 was the only independent prognostic parameter influencing nodal recurrence. Prognostic factors for N1 at presentation and for recurrence are pathological parameters, thus it is not possible before surgery to detect PTMC patients who are at risk. However, we believe that a full treatment protocol should be also indicated in the case of PTMC according to risk stratification and cancer stage as for the conventional counterpart of PTC.
Literature
1.
go back to reference R.A. DeLellis, R.V. Lloyd, P.U. Heitz, Pathology and genetics of tumors of endocrine organs, in World Health Organization classification of tumors, ed. by R.A. DeLellis, R.V. Lloyd, et al. (IARC Press, Lyon, 2004), pp. 64–66 R.A. DeLellis, R.V. Lloyd, P.U. Heitz, Pathology and genetics of tumors of endocrine organs, in World Health Organization classification of tumors, ed. by R.A. DeLellis, R.V. Lloyd, et al. (IARC Press, Lyon, 2004), pp. 64–66
2.
go back to reference S.B. Edge, C.C. Compton, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17, 1471–1474 (2010)CrossRefPubMed S.B. Edge, C.C. Compton, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17, 1471–1474 (2010)CrossRefPubMed
3.
go back to reference Y. Ito, T. Uruno, K. Nakano, Y. Takamura, A. Miya, K. Kobayashi, T. Yokozawa, F. Matsuzuka, S. Kuma, K. Kuma, A. Miyauchi, An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13, 381–387 (2003)CrossRefPubMed Y. Ito, T. Uruno, K. Nakano, Y. Takamura, A. Miya, K. Kobayashi, T. Yokozawa, F. Matsuzuka, S. Kuma, K. Kuma, A. Miyauchi, An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13, 381–387 (2003)CrossRefPubMed
4.
go back to reference E. Baudin, J.P. Travagli, J. Ropers, F. Mancusi, G. Bruno-Bossio, B. Caillou, A.F. Cailleux, J.D. Lumbroso, C. Parmentier, M. Schlumberger, Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83, 553–559 (1998)CrossRefPubMed E. Baudin, J.P. Travagli, J. Ropers, F. Mancusi, G. Bruno-Bossio, B. Caillou, A.F. Cailleux, J.D. Lumbroso, C. Parmentier, M. Schlumberger, Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83, 553–559 (1998)CrossRefPubMed
5.
go back to reference E. Roti, R. Rossi, G. Trasforini, F. Bertelli, M.R. Ambrosio, L. Busutti, E.N. Pearce, L.E. Braverman, E.C. Degli Uberti, Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J. Clin. Endocrinol. Metab. 91, 2171–2178 (2006)CrossRefPubMed E. Roti, R. Rossi, G. Trasforini, F. Bertelli, M.R. Ambrosio, L. Busutti, E.N. Pearce, L.E. Braverman, E.C. Degli Uberti, Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J. Clin. Endocrinol. Metab. 91, 2171–2178 (2006)CrossRefPubMed
6.
go back to reference J.Y. Kwak, E.-K. Kim, M.J. Kim, E.J. Son, W.Y. Chung, C.S. Park, K.-H. Nam, Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann. Surg. Oncol. 16, 1348–1355 (2009)CrossRefPubMed J.Y. Kwak, E.-K. Kim, M.J. Kim, E.J. Son, W.Y. Chung, C.S. Park, K.-H. Nam, Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann. Surg. Oncol. 16, 1348–1355 (2009)CrossRefPubMed
7.
go back to reference I.D. Hay, E.J. Bergstralh, J.R. Goelner, J.R. Ebersold, C.S. Grant, Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114, 1050–1058 (1993)PubMed I.D. Hay, E.J. Bergstralh, J.R. Goelner, J.R. Ebersold, C.S. Grant, Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114, 1050–1058 (1993)PubMed
8.
go back to reference S.M. Chow, S.C.K. Law, J.K. Chan, S.K. Au, S. Yau, W.H. Lau, Papillary microcarcinoma of the thyroid. Prognostic significance of lymph node metastasis and multifocality. Cancer 98, 31–40 (2003)CrossRefPubMed S.M. Chow, S.C.K. Law, J.K. Chan, S.K. Au, S. Yau, W.H. Lau, Papillary microcarcinoma of the thyroid. Prognostic significance of lymph node metastasis and multifocality. Cancer 98, 31–40 (2003)CrossRefPubMed
10.
go back to reference I.D. Hay, C.S. Grant, J.A. van Heerden, J.R. Goellner, J.R. Ebersold, E.J. Bergstralh, Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112, 1139–1146 (1992)PubMed I.D. Hay, C.S. Grant, J.A. van Heerden, J.R. Goellner, J.R. Ebersold, E.J. Bergstralh, Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112, 1139–1146 (1992)PubMed
11.
go back to reference N. Wada, Q.Y. Duh, K. Sugino, H. Iwasaki, K. Kameyama, T. Mimura, K. Ito, H. Takami, Y. Takanashi, Lymph node metastasis from 259 papillary thyroid microcarcinomas. Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann. Surg. 237, 399–407 (2003)PubMedCentralPubMed N. Wada, Q.Y. Duh, K. Sugino, H. Iwasaki, K. Kameyama, T. Mimura, K. Ito, H. Takami, Y. Takanashi, Lymph node metastasis from 259 papillary thyroid microcarcinomas. Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann. Surg. 237, 399–407 (2003)PubMedCentralPubMed
12.
go back to reference K.D. Lin, J.D. Lin, M.J. Huang, H.S. Huang, L.B. Jeng, T.C. Chao, Y.S. Ho, Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int. Surg. 82, 378–381 (1997)PubMed K.D. Lin, J.D. Lin, M.J. Huang, H.S. Huang, L.B. Jeng, T.C. Chao, Y.S. Ho, Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int. Surg. 82, 378–381 (1997)PubMed
13.
go back to reference Y. Ito, T. Jikuzono, T. Higashiyama, S. Asahi, C. Tomoda, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J. Surg. 30, 1821–1828 (2006)CrossRefPubMed Y. Ito, T. Jikuzono, T. Higashiyama, S. Asahi, C. Tomoda, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J. Surg. 30, 1821–1828 (2006)CrossRefPubMed
14.
go back to reference C. Cappelli, M. Castellano, M. Braga, E. Gandossi, I. Pirola, E. De Martino, B. Agosti, E.A. Rosei, Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J. Surg. Oncol. 95, 555–560 (2007)CrossRefPubMed C. Cappelli, M. Castellano, M. Braga, E. Gandossi, I. Pirola, E. De Martino, B. Agosti, E.A. Rosei, Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J. Surg. Oncol. 95, 555–560 (2007)CrossRefPubMed
15.
go back to reference N. Arora, H.K. Turbedian, M.A. Kato, T.A. Moo, R. Zarnegar, T.J. Fahey 3rd, Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 5, 473–477 (2009)CrossRef N. Arora, H.K. Turbedian, M.A. Kato, T.A. Moo, R. Zarnegar, T.J. Fahey 3rd, Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 5, 473–477 (2009)CrossRef
16.
go back to reference J.P. Vandenbroucke, E. von Elm, D.G. Altman, P.C. Gøtzsche, C.D. Mulrow, S.J. Pocock, C. Poole, J.J. Schlesselman, M. Egger, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS. Med. 4, e297 (2007). doi:10.1371/journal.pmed CrossRefPubMedCentralPubMed J.P. Vandenbroucke, E. von Elm, D.G. Altman, P.C. Gøtzsche, C.D. Mulrow, S.J. Pocock, C. Poole, J.J. Schlesselman, M. Egger, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS. Med. 4, e297 (2007). doi:10.​1371/​journal.​pmed CrossRefPubMedCentralPubMed
17.
go back to reference A. Pisanu, I. Reccia, O. Nardello, A. Uccheddu, Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J. Surg. 33, 460–468 (2009)CrossRefPubMed A. Pisanu, I. Reccia, O. Nardello, A. Uccheddu, Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J. Surg. 33, 460–468 (2009)CrossRefPubMed
18.
go back to reference J. Schonberger, J. Marienhagen, A. Agha, S. Rozeboom, E. Bachmeier, H. Schlitt, C. Eilles, Papillary microcarcinoma and papillary cancer of the thyroid B1 cm. Modified definition of the WHO and the therapeutic dilemma. Nuklearmedizin 46, 115–120 (2007)PubMed J. Schonberger, J. Marienhagen, A. Agha, S. Rozeboom, E. Bachmeier, H. Schlitt, C. Eilles, Papillary microcarcinoma and papillary cancer of the thyroid B1 cm. Modified definition of the WHO and the therapeutic dilemma. Nuklearmedizin 46, 115–120 (2007)PubMed
19.
go back to reference S. Grodski, T. Brown, S. Sidhu, A. Gill, B. Robinson, D. Learoyd, M. Sywak, T. Reeve, L. Delbridge, Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144, 1038–1043 (2008)CrossRefPubMed S. Grodski, T. Brown, S. Sidhu, A. Gill, B. Robinson, D. Learoyd, M. Sywak, T. Reeve, L. Delbridge, Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144, 1038–1043 (2008)CrossRefPubMed
20.
go back to reference E.L. Mazzaferri, J. Sipos, Should all patients with subcentimeter thyroid nodules undergo fine-needle aspiration biopsy and pre-operative neck ultrasonography to define the extent of tumor invasion? Thyroid 18, 597–602 (2008)CrossRefPubMed E.L. Mazzaferri, J. Sipos, Should all patients with subcentimeter thyroid nodules undergo fine-needle aspiration biopsy and pre-operative neck ultrasonography to define the extent of tumor invasion? Thyroid 18, 597–602 (2008)CrossRefPubMed
21.
go back to reference M.R. Pelizzo, I.M. Boschin, A. Toniato, C. Pagetta, A. Piotto, P. Bernante, D. Casara, G. Pennelli, D. Rubello, Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl. Med. Commun. 25, 547–552 (2004)CrossRefPubMed M.R. Pelizzo, I.M. Boschin, A. Toniato, C. Pagetta, A. Piotto, P. Bernante, D. Casara, G. Pennelli, D. Rubello, Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl. Med. Commun. 25, 547–552 (2004)CrossRefPubMed
22.
go back to reference I. Sugitani, Y. Fujimoto, Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr. J. 46, 209–216 (1999)CrossRefPubMed I. Sugitani, Y. Fujimoto, Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr. J. 46, 209–216 (1999)CrossRefPubMed
23.
go back to reference Q. Zhao, J. Ming, C. Liu, L. Shi, X. Xu, X. Nie, T. Huang, Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 20, 746–752 (2013)CrossRefPubMed Q. Zhao, J. Ming, C. Liu, L. Shi, X. Xu, X. Nie, T. Huang, Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 20, 746–752 (2013)CrossRefPubMed
24.
go back to reference G. Lupoli, G. Vitale, M. Caraglia, M.R. Fittipaldi, A. Abbruzzese, P. Tagliaferri, A.R. Bianco, Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353, 637–639 (1999)CrossRefPubMed G. Lupoli, G. Vitale, M. Caraglia, M.R. Fittipaldi, A. Abbruzzese, P. Tagliaferri, A.R. Bianco, Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353, 637–639 (1999)CrossRefPubMed
25.
go back to reference G. Mercante, A. Frasoldati, C. Pedroni, D. Formisano, L. Renna, S. Piana, G. Gardini, R. Valcavi, V. Barbieri, Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19, 707–716 (2009)CrossRefPubMed G. Mercante, A. Frasoldati, C. Pedroni, D. Formisano, L. Renna, S. Piana, G. Gardini, R. Valcavi, V. Barbieri, Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19, 707–716 (2009)CrossRefPubMed
26.
go back to reference J.S. Choi, E.-K. Kim, H.J. Moon, J.Y. Kwak, Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Endocrine (2014). doi:10.1007/s120120-014-0293-z J.S. Choi, E.-K. Kim, H.J. Moon, J.Y. Kwak, Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Endocrine (2014). doi:10.​1007/​s120120-014-0293-z
27.
go back to reference H.J. Shin, E.-K. Kim, H.J. Moon, J.H. Yoon, K.-H. Han, J.Y. Kwak, Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma? Endocrine (2013). doi:10.1007/s12020-013-0131-8 PubMed H.J. Shin, E.-K. Kim, H.J. Moon, J.H. Yoon, K.-H. Han, J.Y. Kwak, Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma? Endocrine (2013). doi:10.​1007/​s12020-013-0131-8 PubMed
28.
go back to reference T.Y. Kim, S.J. Hong, M. Kim, W.G. Kim, G. Gong, J.S. Ryu, W.B. Kim, S.-C. Yun, Y.K. Shong, Prognostic parameters for recurrence of papillary thyroid microcarcinoma. B.M.C. Cancer 8, 296 (2008)PubMedCentralPubMed T.Y. Kim, S.J. Hong, M. Kim, W.G. Kim, G. Gong, J.S. Ryu, W.B. Kim, S.-C. Yun, Y.K. Shong, Prognostic parameters for recurrence of papillary thyroid microcarcinoma. B.M.C. Cancer 8, 296 (2008)PubMedCentralPubMed
29.
go back to reference E.J. Kuo, P. Goffredo, J.A. Sosa, S.A. Roman, Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph node metastases: a population-level analysis. Thyroid 23, 1305–1311 (2013)CrossRefPubMedCentralPubMed E.J. Kuo, P. Goffredo, J.A. Sosa, S.A. Roman, Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph node metastases: a population-level analysis. Thyroid 23, 1305–1311 (2013)CrossRefPubMedCentralPubMed
30.
go back to reference K.L. Lin, O.C. Wang, X.H. Zhang, X.X. Dai, X.Q. Hu, J.M. Qu, The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 17, 3294–3300 (2010)CrossRefPubMed K.L. Lin, O.C. Wang, X.H. Zhang, X.X. Dai, X.Q. Hu, J.M. Qu, The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 17, 3294–3300 (2010)CrossRefPubMed
Metadata
Title
Nodal metastasis and recurrence in papillary thyroid microcarcinoma
Authors
Adolfo Pisanu
Alessandra Saba
Mauro Podda
Isabella Reccia
Alessandro Uccheddu
Publication date
01-03-2015
Publisher
Springer US
Published in
Endocrine / Issue 2/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0350-7

Other articles of this Issue 2/2015

Endocrine 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.